To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Department of Education: Public Expenditure
Thursday 12th March 2026

Asked by: Baroness Shawcross-Wolfson (Conservative - Life peer)

Question to the HM Treasury:

To ask His Majesty's Government how much resource and capital was allocated to the Department of Education in the Spending Review 2025 for (1) 2026–27, (2) 2027–28, and (3) 2028–29; whether they have revised the spending allocations for that department at any point since the Spending Review 2025 on 11 June 2025; and if so, whether they will publish the revised spending allocations for capital and resource in each of those years.

Answered by Lord Livermore - Financial Secretary (HM Treasury)

All departments’ Departmental Expenditure Limit (DEL) budgets are freely available on GOV.UK.

DfE’s DEL budgets allocated at the Spending Review 2025 were:

£bn

2026-27

2027-28

2028-29

RDEL

98.3

100.1

101.5

CDEL

8.3

7.7

7.7

Revised budgets were published at the Autumn Budget in 2025:

£bn

2026-27

2027-28

2028-29

RDEL

98.3

100.2

101.0

CDEL

8.3

7.7

7.7


Written Question
NHS: Pay
Wednesday 11th March 2026

Asked by: Baroness Shawcross-Wolfson (Conservative - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what the cash value is of the productivity and efficiency savings they assumed in their submission to the NHS Pay Review Body for the NHS Agenda for Change staff pay award 2026–27; and whether they assumed those savings could be released (1) at the beginning of the financial year, or (2) during the financial year.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

At the 2024 Autumn Statement, the Government reaffirmed its commitment to a 2% annual productivity growth target for the National Health Service. This is a stretching but essential ambition to ensure the NHS can meet rising demand within a tight financial settlement and return to pre-pandemic productivity levels. Detail on this was provided as part of the pay review body written evidence to give context to the wider NHS England financial position against which decisions are set.

Currently NHS productivity is running ahead of the 2% target, and increased by 2.8% in the first seven months of this financial year. This builds on the 2.7% growth between the 2024/25 and 2023/24 financial years. Consequently, we remain confident in delivering the 2% target.

The pay review body evidence did not set an explicit efficiency target. In practice, efficiency savings as a percentage run well ahead of 2% because they including non-recurrent savings and technical efficiencies, for instance reductions in agency costs, that are outside of productivity calculations. In 2024/25, NHS systems planned what was then the most ambitious efficiency and savings measures to date, targeting £9.3 billion, the equivalent to 6.1% of their total allocation. In 2025/26, systems have planned £11.1 billion of efficiencies and savings, 7.1% of the total allocation. NHS England will finalise planned efficiency and savings for the 2026/27 financial year as part of the normal planning process that is currently underway. Efficiencies are delivered throughout the course of the financial year, rather than all upfront at the start of the year.


Written Question
Prescription Drugs: Cost Effectiveness
Wednesday 11th March 2026

Asked by: Baroness Shawcross-Wolfson (Conservative - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether they still plan to increase the National Institute for Health and Care Excellence cost per quality-adjusted life years thresholds in April; and what steps they will take to implement that increase.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The National Institute for Health and Care Excellence (NICE) currently assesses value for money for the National Health Service by applying a standard cost-effectiveness range of £20,000 to £30,000 per quality adjusted life year (QALY) gained over and above current treatments. As part of the landmark pharmaceuticals trade deal with the United States of America, it has been agreed that the cost-effectiveness threshold will be increased to £25,000 to £35,000 per QALY.

My Rt Hon. Friend, the Secretary of State for Health and Social Care, does not currently have the legal power to direct NICE to amend the cost-effectiveness threshold used in its technology appraisal or highly specialised technology programmes. The Government has therefore proceeded to amend the NICE regulations, to give ministers a limited power of direction to set the core cost-effectiveness threshold that NICE uses in the development of guidance, and remove the requirement for NICE to consult on methods changes where these result from a ministerial direction. The regulation change has been made by a statutory instrument which was laid before Parliament on 3 March 2026 and, subject to the will of Parliament, will come into force on 24 March 2026. In line with the United Kingdom-United States’ deal, NICE will implement the cost-effectiveness threshold increase in April 2026, following a direction from my Rt Hon. Friend, the Secretary of State for Health and Social Care.


Written Question
Prescription Drugs: Cost Effectiveness
Wednesday 11th March 2026

Asked by: Baroness Shawcross-Wolfson (Conservative - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the number of National Institute for Health and Care Excellence appraisals which are paused pending increases in the cost per quality-adjusted life year threshold in April.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

There are currently two appraisals paused, at the request of the company, until the National Institute for Health and Care Excellence (NICE) has the power to apply the new cost-effectiveness threshold:

  • Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over [ID6407]; and
  • Ripretinib for treating advanced gastrointestinal stromal tumours after three or more treatments (review of TA881) [ID6496].

NICE anticipates that its cost-effectiveness threshold will increase in April 2026 and will provide a further update to stakeholders at that time.


Written Question
NHS: Cost Effectiveness
Wednesday 11th March 2026

Asked by: Baroness Shawcross-Wolfson (Conservative - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what estimate they have made of the cash value of the productivity and efficiency savings to be made by NHS England, integrated care boards and NHS providers in order to fund the NHS Agenda for Change staff pay award 2026–27.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government has accepted the NHS Pay Review Body (NHSPRB) recommendation for a 2026/27 headline pay award, for all National Health Service staff on Agenda for Change (AfC), of a 3.3% pay rise effective from April 2026. We hugely appreciate the work of so many talented staff across the NHS. Accepting the recommendation gives NHS staff on AfC a deserved real terms pay rise.

The additional pressure above 2.5% affordability will be managed by the Department and the arms length bodies, including NHS England’s central budgets, but will not be paid for by cutting frontline services or an additional efficiency ask of integrated care boards and providers.

At the 2024 Autumn Statement and in our NHSPRB evidence, the Government reaffirmed its commitment to a 2% annual productivity growth target for the NHS and productivity is currently ahead of this target at 2.8% for the first seven months in this financial year. In 2025/26, systems have planned £11.1 billion of efficiencies and savings, or 7.1% of the total allocation. The planned efficiency and savings for the 2026/27 financial year will be finalised as part of the normal planning process that is currently underway.

Both efficiency and productivity performance is monitored on a monthly basis as part of our routine financial management to ensure the NHS lives within its budget.


Written Question
NHS: Cost Effectiveness
Wednesday 11th March 2026

Asked by: Baroness Shawcross-Wolfson (Conservative - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to monitor the delivery of efficiency savings by NHS England, integrated care boards and NHS providers in order to fund the NHS Agenda for Change staff pay award 2026–27; and what steps they plan to take to ensure that those savings do not impact frontline services.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government has accepted the NHS Pay Review Body (NHSPRB) recommendation for a 2026/27 headline pay award, for all National Health Service staff on Agenda for Change (AfC), of a 3.3% pay rise effective from April 2026. We hugely appreciate the work of so many talented staff across the NHS. Accepting the recommendation gives NHS staff on AfC a deserved real terms pay rise.

The additional pressure above 2.5% affordability will be managed by the Department and the arms length bodies, including NHS England’s central budgets, but will not be paid for by cutting frontline services or an additional efficiency ask of integrated care boards and providers.

At the 2024 Autumn Statement and in our NHSPRB evidence, the Government reaffirmed its commitment to a 2% annual productivity growth target for the NHS and productivity is currently ahead of this target at 2.8% for the first seven months in this financial year. In 2025/26, systems have planned £11.1 billion of efficiencies and savings, or 7.1% of the total allocation. The planned efficiency and savings for the 2026/27 financial year will be finalised as part of the normal planning process that is currently underway.

Both efficiency and productivity performance is monitored on a monthly basis as part of our routine financial management to ensure the NHS lives within its budget.


Written Question
NHS: Pay
Wednesday 11th March 2026

Asked by: Baroness Shawcross-Wolfson (Conservative - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what estimate they have made of (1) the total cost of the 2026–27 pay award for NHS Agenda for Change staff in England, and (2) the cost of that award above the affordability assumption set out in their evidence to the NHS Pay Review Body.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government has accepted the NHS Pay Review Body recommendation for the 2026/27 headline pay award, for all National Health Service staff on Agenda for Change terms and conditions in England, of a 3.3% consolidated pay rise effective from April 2026.

The pay uplift is above the Office for Budget Responsibility’s forecast inflation of 2.2% for 2026/27 and delivers a real terms pay rise for NHS staff.

The total cost for the 2026/27 pay award is estimated to be £3,250 million, and the likely impact above the 2.5% affordability assumption is estimated to be approximately £800 million. However, the exact cost will vary depending on the workforce size and composition during the year.

This additional pressure above affordability will be managed by the Department and our arms length bodies, including NHS England central budgets, but the pay increases will not be paid for by cutting frontline services.

It is vital that pay awards are fair for both workers and the taxpayer, so public services can deliver high-quality services across the country.


Written Question
NHS England: Staff
Monday 2nd March 2026

Asked by: Baroness Shawcross-Wolfson (Conservative - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 2 February (HL13305), whether they expect a significant reduction in headcount in NHS England; and when they expect to reach their target for headcount reduction from the abolition of NHS England.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government’s ambition remains to reduce staff numbers by up to 50% across the Department of Health and Social Care, NHS England, and the integrated care boards. These reductions will be made by March 2028. NHS England’s voluntary redundancy scheme opened on 1 December and closed for applications on Tuesday 16 December. Colleagues have now been informed whether applications to the scheme were successful, however applications can be withdrawn at any time before final agreements are signed so we cannot yet confirm final numbers. The earliest date NHS England colleagues will start to leave under the scheme is 31 March. Our ambition is to let as many people leave voluntarily as possible and alongside ongoing recruitment controls and natural staff turnover, and we believe this will allow us to make significant progress towards the 50% headcount reduction.


Written Question
Integrated Care Boards: Staff
Thursday 26th February 2026

Asked by: Baroness Shawcross-Wolfson (Conservative - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 2 February (HL13305), what was the headcount at integrated care boards in (1) July 2024, and (2) the most recent period for which figures are available.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

NHS England publishes monthly NHS Workforce Statistics which includes detailed statistics on staffing by individual trust and integrated care board (ICB). This publication has been used to supply a response to this question.

As of July 2024, there were 24,780 headcount staff working in ICBs across England. As of November 2025, this figure has decreased by 22 to 24,758 headcount staff working in ICBs across England. These numbers cover all staff employed directly by ICBs.

In April 2025 staff from two Commissiong Support Units, the NHS North of England Commissioning Support Unit and the NHS Midlands and Lancashire Commissioning Support Unit, transferred into the employment of their local ICBs, namely the NHS North East and Cumbria ICB and the NHS Staffordshire and Stoke-on-Trent ICB respectively. The impact of these moves was a one-off increase of 450 ICB staff across the two transfers.


Written Question
Senior Civil Servants: Public Appointments
Tuesday 24th February 2026

Asked by: Baroness Shawcross-Wolfson (Conservative - Life peer)

Question to the Cabinet Office:

To ask His Majesty's Government, further to the Written Answer by Baroness Anderson of Stoke-on-Trent on 28 January (HL14077), whether they will publish the changes they plan to make to the hiring criteria for senior civil servants, as set out in the speech by the Chief Secretary to the Prime Minister on 20 January.

Answered by Baroness Anderson of Stoke-on-Trent - Baroness in Waiting (HM Household) (Whip)

Our approach to hiring for the Senior Civil Service (SCS) is changing to place greater value on frontline delivery, innovation, and private sector experience. Departments and agencies have authority to determine their practices and procedures for the recruitment of staff to the Civil Service, including the Senior Civil Service.

In accordance with the Civil Service Recruitment Principles, departments must provide all potential applicants with information about the nature and level of each role, criteria against which they will be assessed, and details of the selection process and the total remuneration available. However, there are no plans to publish internal-facing guidance to the public domain, as it constitutes HR-to-HR guidance designed for departments to integrate into their respective policies and processes.